skip to Main Content

Killer Cell Immunotherapy Offers Potential Cure for Advanced Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
A new approach to treating pancreatic cancer using ‘educated killer cells’ has shown promise, according to early research by Queen Mary University of London.

The new cell-based immunotherapy, which has not yet been tested in humans with pancreatic cancer, led to mice being completely cancer-free, including cancer cells that had already spread to the liver and lungs. Read more . . . 

Back To Top